Approved Symbol |
Approved Name |
Location |
No. of Studies (Positive/Negative/Trend) |
JAK1 |
Janus kinase 1 |
1p32.3-p31.3 |
1(0/1/0)
|
CACNA1S |
calcium channel, voltage-dependent, L type, alpha 1S subunit |
1q32 |
1(0/1/0)
|
RABGAP1L |
RAB GTPase activating protein 1-like |
1q24 |
1(0/1/0)
|
MYOM3 |
myomesin 3 |
1p36 |
1(0/0/1)
|
DISC1 |
disrupted in schizophrenia 1 |
1q42.1 |
18(10/7/1)
|
PLXNA2 |
plexin A2 |
1q32.2 |
1(1/0/0)
|
CNR2 |
cannabinoid receptor 2 (macrophage) |
1p |
1(1/0/0)
|
DCAF6 |
DDB1 and CUL4 associated factor 6 |
1q23.3 |
1(0/1/0)
|
GJA5 |
gap junction protein, alpha 5, 40kDa |
1q21.2 |
1(1/0/0)
|
GRIK3 |
glutamate receptor, ionotropic, kainate 3 |
1p34.3 |
1(1/0/0)
|
MIR137 |
microRNA 137 |
1p21.3 |
1(1/0/0)
|
GCLM |
glutamate-cysteine ligase, modifier subunit |
1p21 |
1(0/0/1)
|
MTHFR |
methylenetetrahydrofolate reductase (NAD(P)H) |
1p36.3 |
16(10/6/0)
|
FMO5 |
flavin containing monooxygenase 5 |
1q21.1 |
1(1/0/0)
|
LINC01141 |
long intergenic non-protein coding RNA 1141 |
1p36.12 |
1(0/0/1)
|
ATP1A2 |
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
1q23.2 |
1(1/0/0)
|
MTR |
5-methyltetrahydrofolate-homocysteine methyltransferase |
1q43 |
2(1/1/0)
|
EDARADD |
EDAR-associated death domain |
1q42.3 |
1(1/0/0)
|
PTBP2 |
polypyrimidine tract binding protein 2 |
1p21.3 |
1(0/0/1)
|
GJA8 |
gap junction protein, alpha 8, 50kDa |
1q21.1 |
1(1/0/0)
|
ATP1A1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
1p13 |
1(1/0/0)
|
PTGFR |
prostaglandin F receptor (FP) |
1p31.1 |
1(1/0/0)
|
DAB1 |
Dab, reelin signal transducer, homolog 1 (Drosophila) |
1p32-p31 |
1(0/1/0)
|
CACNA1E |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
1q25.3 |
1(1/0/0)
|
EXTL1 |
exostosin-like glycosyltransferase 1 |
1p36.1 |
1(1/0/0)
|
RGS5 |
regulator of G-protein signaling 5 |
1q23.1 |
1(0/0/1)
|
LRRIQ3 |
leucine-rich repeats and IQ motif containing 3 |
1p31.1 |
1(0/0/1)
|
CHD1L |
chromodomain helicase DNA binding protein 1-like |
1q21.1 |
1(1/0/0)
|
PPIEL |
peptidylprolyl isomerase E-like pseudogene |
1p34.2 |
1(0/0/1)
|
TNR |
tenascin R |
1q24 |
2(0/2/0)
|
PER3 |
period circadian clock 3 |
1p36.23 |
7(3/4/0)
|
C1orf110 |
chromosome 1 open reading frame 110 |
1q23.3 |
2(1/0/1)
|
ANKRD35 |
ankyrin repeat domain 35 |
1q21.1 |
1(1/0/0)
|
HTR6 |
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled |
1p36-p35 |
3(1/2/0)
|
RGS4 |
regulator of G-protein signaling 4 |
1q23.3 |
6(3/2/1)
|
IL10 |
interleukin 10 |
1q31-q32 |
1(0/1/0)
|
NPPB |
natriuretic peptide B |
1p36.2 |
1(1/0/0)
|
KCNN3 |
potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3 |
1q21.3 |
7(1/6/0)
|
RGS7 |
regulator of G-protein signaling 7 |
1q43 |
1(0/1/0)
|
GSTM1 |
glutathione S-transferase mu 1 |
1p13.3 |
1(1/0/0)
|
NPHP4 |
nephronophthisis 4 |
1p36 |
1(1/0/0)
|
NFIA |
nuclear factor I/A |
1p31.3-p31.2 |
1(0/1/0)
|
RLF |
rearranged L-myc fusion |
1p32 |
1(0/1/0)
|
CFAP57 |
cilia and flagella associated protein 57 |
1p34.2 |
1(0/1/0)
|
TAS1R3 |
taste receptor, type 1, member 3 |
1p36 |
1(0/0/1)
|
ARV1 |
ARV1 homolog (S. cerevisiae) |
1q42.2 |
1(0/0/1)
|
OLFM3 |
olfactomedin 3 |
1p22 |
1(1/0/0)
|
PRKCZ |
protein kinase C, zeta |
1p36.33-p36.2 |
1(1/0/0)
|
TSNAX |
translin-associated factor X |
1q42.2 |
4(3/1/0)
|
IFI44L |
interferon-induced protein 44-like |
1p22.3 |
1(0/1/0)
|
DNAH14 |
dynein, axonemal, heavy chain 14 |
1q42.13 |
1(0/0/1)
|
MPC2 |
mitochondrial pyruvate carrier 2 |
1q24 |
1(0/1/0)
|
ATAD3C |
ATPase family, AAA domain containing 3C |
1p36.33 |
1(0/0/1)
|
NEK7 |
NIMA-related kinase 7 |
1q31.3 |
2(0/1/1)
|
DNAJC16 |
DnaJ (Hsp40) homolog, subfamily C, member 16 |
1p36.1 |
1(0/1/0)
|
MIR2682 |
microRNA 2682 |
1 |
1(1/0/0)
|
WDR65 |
cilia and flagella associated protein 57 |
1p34.2 |
0
|
STX12 |
syntaxin 12 |
1p35.3 |
1(0/1/0)
|
CHRNB2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) |
1q21.3 |
1(1/0/0)
|
ZNF678 |
zinc finger protein 678 |
1q42.13 |
1(0/1/0)
|
ROR1 |
receptor tyrosine kinase-like orphan receptor 1 |
1p31.3 |
1(0/0/1)
|
ALDH9A1 |
aldehyde dehydrogenase 9 family, member A1 |
1q24.1 |
1(0/1/0)
|
AGT |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
1q42.2 |
1(1/0/0)
|
PRKACB |
protein kinase, cAMP-dependent, catalytic, beta |
1p36.1 |
1(0/1/0)
|
HCRTR1 |
hypocretin (orexin) receptor 1 |
1p33 |
1(1/0/0)
|
FBXO28 |
F-box protein 28 |
1q42.12 |
1(0/1/0)
|
TMEM222 |
transmembrane protein 222 |
1p36.11 |
1(0/0/1)
|
NUF2 |
NUF2, NDC80 kinetochore complex component |
1q23.3 |
1(1/0/0)
|
NME7 |
NME/NM23 family member 7 |
1q24.2 |
1(0/1/0)
|
HTR1D |
5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled |
1p36.3-p34.3 |
1(0/1/0)
|
RYR2 |
ryanodine receptor 2 (cardiac) |
1q43 |
1(1/0/0)
|
CHRM3 |
cholinergic receptor, muscarinic 3 |
1q43 |
1(0/1/0)
|
FAM20B |
family with sequence similarity 20, member B |
1q25.2 |
1(0/1/0)
|
NGF |
nerve growth factor (beta polypeptide) |
1p13.1 |
2(1/1/0)
|
BCL9 |
B-cell CLL/lymphoma 9 |
1q21 |
1(1/0/0)
|
ASTN1 |
astrotactin 1 |
1q25.2 |
1(1/0/0)
|
IRF2BP2 |
interferon regulatory factor 2 binding protein 2 |
1q42.3 |
1(0/1/0)
|
FABP3 |
fatty acid binding protein 3, muscle and heart |
1p33-p32 |
2(1/1/0)
|
AVPR1B |
arginine vasopressin receptor 1B |
1q32 |
4(3/1/0)
|
VAMP3 |
vesicle-associated membrane protein 3 |
1p36.23 |
1(0/1/0)
|
LRP8 |
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor |
1p32.3 |
1(1/0/0)
|
FAAH |
fatty acid amide hydrolase |
1p35-p34 |
2(0/2/0)
|
RC3H1 |
ring finger and CCCH-type domains 1 |
1q25.1 |
1(0/1/0)
|
ACP6 |
acid phosphatase 6, lysophosphatidic |
1q21 |
1(1/0/0)
|
LEPR |
leptin receptor |
1p31 |
1(1/0/0)
|
PDE4B |
phosphodiesterase 4B, cAMP-specific |
1p31 |
3(1/2/0)
|
KLHL20 |
kelch-like family member 20 |
1q25.1 |
1(0/1/0)
|
MTOR |
mechanistic target of rapamycin (serine/threonine kinase) |
1p36 |
1(0/0/1)
|
PLD5 |
phospholipase D family, member 5 |
1q43 |
1(0/1/0)
|